NCT00636649View on ClinicalTrials.gov

Escitalopram Treatment of Night Eating Syndrome

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

July 31, 2011

Conditions
Night Eating Syndrome
Interventions
DRUG

Escitalopram

10-20 mg

DRUG

Placebo

Placebo

Trial Locations (2)

27710

Duke University Medical Center, Durham

63103

Saint Louis University, St Louis

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

St. Louis University

OTHER

lead

Duke University

OTHER

NCT00636649 - Escitalopram Treatment of Night Eating Syndrome | Biotech Hunter | Biotech Hunter